Chan HL - Search Results

1

No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection.

Cathcart AL, Chan HL, Bhardwaj N, Liu Y, Marcellin P, Pan CQ, Shalimar, Buti M, Cox S, Parhy B, Zhou E, Martin R, Chang S, Lin L, Flaherty JF, Kitrinos KM, Gaggar A, Izumi N, Lim YS. Cathcart AL, et al. Among authors: chan hl. Antimicrob Agents Chemother. 2018 Sep 24;62(10):e01064-18. doi: 10.1128/AAC.01064-18. Print 2018 Oct. Antimicrob Agents Chemother. 2018. PMID: 30038044 Free PMC article.

2

The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis.

Chan HL, Tang JL, Tam W, Sung JJ. Chan HL, et al. Aliment Pharmacol Ther. 2001 Dec;15(12):1899-905. doi: 10.1046/j.1365-2036.2001.01135.x. Aliment Pharmacol Ther. 2001. PMID: 11736720

3

Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection.

Chan HL, Tsang SW, Liew CT, Tse CH, Wong ML, Ching JY, Leung NW, Tam JS, Sung JJ. Chan HL, et al. Am J Gastroenterol. 2002 Feb;97(2):406-12. doi: 10.1111/j.1572-0241.2002.05478.x. Am J Gastroenterol. 2002. PMID: 11866280

4

Molecular virology in chronic hepatitis B: genotypes.

Wong GL, Chan HL. Wong GL, et al. Among authors: chan hl. Hosp Med. 2005 Jan;66(1):13-6. doi: 10.12968/hmed.2005.66.1.17529. Hosp Med. 2005. PMID: 15686160 Review.

5

Long-term lamivudine treatment is associated with a good maintained response in severe acute exacerbation of chronic HBeAg-negative hepatitis B.

Chan HL, Wong VW, Hui AY, Tsang SW, Chan JL, Chan HY, Wong GL, Sung JJ. Chan HL, et al. Among authors: chan hy, chan jl. Antivir Ther. 2006;11(4):465-71. Antivir Ther. 2006. PMID: 16856620 Clinical Trial.

6

Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.

Wong VW, Wong GL, Tsang SW, Hui AY, Chim AM, Yiu KK, Chan HY, Chan FK, Sung JJ, Chan HL. Wong VW, et al. Among authors: chan hy, chan hl, chan fk. Antivir Ther. 2008;13(4):571-9. Antivir Ther. 2008. PMID: 18672536 Clinical Trial.

7

Surrogate end points and long-term outcome in patients with chronic hepatitis B.

Wong VW, Wong GL, Chim AM, Choi PC, Chan AW, Tsang SW, Hui AY, Chan HY, Sung JJ, Chan HL. Wong VW, et al. Among authors: chan hy, chan hl, chan aw. Clin Gastroenterol Hepatol. 2009 Oct;7(10):1113-20. doi: 10.1016/j.cgh.2009.05.025. Epub 2009 Jun 23. Clin Gastroenterol Hepatol. 2009. PMID: 19500693 Clinical Trial.

8

Durability of peginterferon alfa-2b treatment at 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.

Wong VW, Wong GL, Yan KK, Chim AM, Chan HY, Tse CH, Choi PC, Chan AW, Sung JJ, Chan HL. Wong VW, et al. Among authors: chan hy, chan hl, chan aw. Hepatology. 2010 Jun;51(6):1945-53. doi: 10.1002/hep.23568. Hepatology. 2010. PMID: 20209602

9

Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy.

Lui YY, Tsoi KK, Wong VW, Kao JH, Hou JL, Teo EK, Mohamed R, Piratvisuth T, Han KH, Mihm U, Wong GL, Chan HL. Lui YY, et al. Among authors: chan hl. Antivir Ther. 2010;15(2):145-55. doi: 10.3851/IMP1496. Antivir Ther. 2010. PMID: 20386069

10

Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B.

Wong VW, Wong GL, Yiu KK, Chim AM, Chu SH, Chan HY, Sung JJ, Chan HL. Wong VW, et al. Among authors: chan hy, chan hl. J Hepatol. 2011 Feb;54(2):236-42. doi: 10.1016/j.jhep.2010.06.043. Epub 2010 Sep 7. J Hepatol. 2011. PMID: 21030105

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,246 results

Search Page

Filters